WHO types A and AB thymomas: not always benign.

Area of Science:

• Oncology
• Pathology

Background:

• The 2004 World Health Organization (WHO) classification categorizes thymic tumors into five subtypes.
• Thymomas subtypes A and AB are generally considered benign but may exhibit malignant potential.

Purpose of the Study:

• To evaluate the clinical behavior of thymoma subtypes A and AB.
• To assess the potential for recurrence and metastasis in these thymic neoplasms.

Main Methods:

• Retrospective analysis of 71 cases of thymoma subtypes A and AB from a large institutional database.
• Review of 500 thymic epithelial tumors to identify relevant cases.
• Chart review for clinical history and follow-up data.

Main Results:

• Eighteen out of 37 patients (49%) with available follow-up data experienced recurrent or metastatic disease.
• Recurrences were observed an average of 62 months post-diagnosis.
• Statistically significant differences in survival were noted between patients with and without recurrence (P=0.001 and P=0.005).

Conclusions:

• Thymoma subtypes A and AB demonstrate a potential for malignant behavior, contrary to prior assumptions.
• Long-term clinical monitoring is warranted for patients diagnosed with thymoma subtypes A and AB.
• The study highlights a poor correlation between the WHO classification and the actual tumor behavior.